The effectiveness of short-term cognitive behavioral therapy in the complex treatment of idiopathic restless legs syndrome with chronic insomnia

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Aim. To investigate the effectiveness of the short-term protocol of cognitive behavioral therapy RELEGS M. Hornyak et al. in complex treatment to improve the quality of sleep, reduce the symptoms of depression, anxiety, suicidal thoughts in patients with primary SBN comorbid with chronic insomnia.

Methods. Study participants: 68 patients with primary restless legs syndrome with comorbid chronic insomnia. Women — 56 (average age 52.1±10.3 years), men — 12 (average age 50.3±9.4 years). The severity of restless legs syndrome is moderate to severe. The average age of the onset of the disease is 18–48 years, the duration of the course of the disease is on average 14–15 years. Taking various medications for the management of SBN for an average of 4–5 years. Study design: a randomized controlled trial, after screening — 26 patients were assigned to the main group, underwent combined treatment, took a prolonged form of Pramipexole (Mirapex-PD, 1.5 mg.) and underwent the RELEGS CBT protocol (Restless Legs Skills program, Hornyak, Grossmann, 2018), which integrates the cognitive behavioral insomnia protocol (Morin, 2007) and Mindfulness-Based Stress therapy (Mindfulness-Based Stress Reduction, Bablas, 2016). The control group consisted of 24 people who received only general recommendations on sleep hygiene once. Both groups were treated with dopaminergic agonists under the supervision of a neurologist. Research methods: IRLS, ISI, DBAS-16, sleep diary analysis, actigraphy, BDI, SBQ-R, BAI.

Results. The use of the CBT protocol in combination therapy with prolonged-acting dopaminergic agonists in patients with primary restless leg syndrome (mild and moderate severity) with comorbid chronic insomnia, in contrast to simple one-time general recommendations on sleep hygiene, is more effective for reducing dysfunctional behaviors, the spectrum of reinsurance and avoidance behavior both in relation to sleep and symptoms of restless legs. In patients with primary restless legs syndrome who underwent CBT, greater mental well-being was observed, which was expressed in a decrease in the severity of symptoms of insomnia, anxiety, and suicidal behavior after completion and persisted after 3 months of follow-up.

Conclusion. As part of a personalized comprehensive approach, along with a drug-based approach and general recommendations for sleep hygiene, the use of short-term CBT (4 sessions, 60 minutes each) can significantly improve mental well-being, improve the quality of sleep of patients with restless legs syndrome with comorbid chronic insomnia.

Full Text

Restricted Access

About the authors

Aleksey I. Melekhin

P.A. Stolypin Humanitarian Institute

Author for correspondence.
Email: clinmelehin@yandex.ru
ORCID iD: 0000-0001-5633-7639
SPIN-code: 6982-1468
Russian Federation, 107076, Moscow, Bukhvostova str., 1-ya, 12/11, bldg. 20

References

  1. Мелёхин А.И. Когнитивно-поведенческая психотерапия расстройств сна. Практическое руководство. М.: ГЭОТАР-Медиа. 2020; 496 с. [Melyohin A.I. Kognitivno-povedencheskaya psihoterapiya rasstrojstv sna. Prakticheskoe rukovodstvo. M.: GEOTAR-Media. 2020; 496 p. (In Russ.)]
  2. Мелёхин А.И. Применение когнитивно-поведенческой психотерапии при лечении синдрома беспокойных ног. Консультативн. психол. и психотерап. 2018; 26 (2): 53–78. [Melyohin A.I. Primenenie kognitivno-povedencheskoj psihoterapii pri lechenii sindroma bespokojnyh nog. Konsul’tativnaya psihologiya i psihoterapiya. 2018; 26 (2). 53–78. (In Russ.)] doi: 10.17759/cpp.2018260204.
  3. Para K.S., Chow C.A., Nalamada K. Suicidal thought and behavior in individuals with restless legs syndrome. Sleep Med. 2019; 54 (1): 1–7. doi: 10.1016/j.sleep.2018.09.019.
  4. Song M.L., Park K.M., Motamedi G. Cognitive behavioral therapy for insomnia in restless legs syndrome patients. Sleep Med. 2020; 74 (3): 227–234. doi: 10.1016/j.sleep.2020.07.011.
  5. Becker P.M., Sharon D. Mood disorders in restless legs syndrome (Willis–Ekbom disease). J. Clin. Psychiatry. 2014; 75 (3): 679–694. doi: 10.4088/JCP.13r08692.
  6. Song M.L., Oldham M.A., Park K.M. et al. Comparison of impact of insomnia on depression and quality of life in restless legs syndrome/Willis–Ekbom disease and primary insomnia patients. Sleep Med. 2015; 16 (11): 1403–1418. doi: 10.1016/j.sleep.2015.06.019.
  7. Broman J.E., Mallon L., Hetta J. Restless legs syndrome and its relationship with insomnia symptoms and daytime distress. Epidemiol. Survey in Sweden. 2008; 62 (1): 472–485. doi: 10.1111/j.1440-1819.2008.01825.x.
  8. Tang N.K., Goodchild C.E., Salkovskis P.M. Hybrid cognitive-behaviour therapy for individuals with insomnia and chronic pain: a pilot randomised controlled trial. Behav. Res. Ther. 2012; 50 (9): 814–821. doi: 10.1016/j.brat.2012.08.006.
  9. Pigeon W.R., Moynihan J., Matteson-Rusby S. et al. Comparative effectiveness of CBT interventions for co-morbid chronic pain & insomnia: a pilot study. Behav. Res. Ther. 2012; 50 (4): 685–699. doi: 10.1016/j.brat.2012.07.005.
  10. Zhuang S., Na M., Winkelman J.W. Association of restless legs syndrome with risk of suicide and self-harm. JAMA Network Open. 2019; 2 (8): 1–19. doi: 10.1001/jamanetworkopen.2019.9966.
  11. Harrison E.G., Keating J.L., Morgan P.E. Non-pharmacological interventions for restless legs syndrome: a systematic review of randomised controlled trials. Disabil. Rehabil. 2018; 21 (1): 19–27. doi: 10.1080/09638288.2018.145387561180.
  12. Fuhs A., Bentama D., Antkowiak R. et al. Effects of short- and long-term variations in RLS severity on perceived health status — the COR-study. PLoS One. 2014; 12 (9): 94–121. doi: 10.1371/journal.pone.0094821.
  13. Riemann D., Baglioni C., Bassetti C. et al. European guideline for the diagnosis and treatment of insomnia. J. Sleep Res. 2017; 26 (3): 675–700. doi: 10.1111/jsr.12594.
  14. Nishikawa K., Kuriyama K., Yoshiike T. et al. Effects of cognitive behavioral therapy for insomnia on subjective-objective sleep discrepancy in patients with primary insomnia: a small-scale cohort pilot study. Int. J. Behav. Med. 2021; 31 (2): 10–19. doi: 10.1007/s12529-021-09969.
  15. Koffel E., Amundson E., Wisdom J.P. Exploring the meaning of cognitive behavioral therapy for insomnia for patients with chronic pain. Pain Med. 2020; 21 (1): 67–75. doi: 10.1093/pm/pnz144.
  16. Cronlein T., Wagner S., Langguth B. et al. Are dysfunctional attitudes and beliefs about sleep unique to primary insomnia? Sleep Med. 2014; 15 (4): 14–25. doi: 10.1016/j.sleep.2014.06.018.
  17. Morin C.M., Espie C.A. Insomnia: a clinical guide to assessment and treatment. NY: Springer Science & Business Media. 2007; 219 р.
  18. Rinaldi F., Galbiati A., Marelli S. et al. Defining the phenotype of restless legssyndrome/Willis–Ekbom disease (RLS/WED): a clinical and polysomnographic study. J. Neurol. 2016; 39 (4): 26–38. doi: 10.1007/s00415-015-7994-y.
  19. Earley C.J., Silber M.H. Restless legs syndrome: understanding its consequences and the need for better treatment. Sleep Med. 2010; 11 (9): 807–815. doi: 10.1016/j.sleep.2010.07.007.
  20. Castillo P.R., Mera R.M., Fredrickson P.A. et al. Psychological distress in patients with restless legs syndrome (Willis–Ekbom disease): a population-based doorto-door survey in rural Ecuador. BMC Res. Notes. 2014; 7 (3): 9–21. doi: 10.1186/1756-0500-7-911.
  21. Hornyak M., Grossmann C., Kohnen R. Cognitive behavioural group therapy to improve patients’ strategies for coping with restless legs syndrome: a proof-of-concept trial. J. Neurol. Neurosurg. Psychiatry. 2008; 79 (7): 823–835. doi: 10.1136/jnnp.2007.138867.
  22. Bablas V., Yap K., Cunnington D. Mindfulness-based stress reduction for restless legs syndrome: A proof of concept trial. Mindfulness. 2016; 7 (2): 396–408. doi: 10.1007/s12671-015-0457-9.
  23. Edinger J.D., Fins A.I., Sullivan R.J. et al. Comparison of cognitive-behavioral therapy and clonazepam for treating periodic limb movement disorder. Sleep. 1996; 19 (5): 442–453. doi: 10.1186/1477-7525-11-65.
  24. Belleville G., Cousineau H., Levrier K. et al. Meta-analytic review of the impact of cognitive-behavior therapy for insomnia on concomitant anxiety. Clin. Psychol. Rev. 2011; 31 (5): 638–652. doi: 10.1016/j.cpr.2011.02.004.
  25. Cronlein T., Langguth B., Popp R. et al. Regensburg insomnia scale (RIS): a new short rating scale for the assessment of psychological symptoms and sleep in insomnia; study design: development and validation of a new short selfrating scale in a sample of 218 patients suffering from insomnia and 94 healthy controls. Health Qual. Life Outcome. 2013; 11 (2): 65–77. doi: 10.1186/1477-7525-12-47.
  26. Harvey A.G., Belanger L., Talbot L. et al. Comparative efficacy of behavior therapy, cognitive therapy, and cognitive behavior therapy for chronic insomnia: a randomized controlled trial. J. Consult. Clin. Psychol. 2014; 82 (1): 670–683. doi: 10.1037/a0036606.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2021 Melekhin A.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 75562 от 12 апреля 2019 года.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies